Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.2.1.23 (beta-galactosidase)
 14,648 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Urinary excretion of lactate dehydrogenase (LDH), glutathione-S-transferase (GST), leucine arylamidase (LAS), gamma-glutamyltransferase (GGT), beta-galactosidase (GAL), beta-N-acetyl-D-glucosaminidase (NAG), sodium, and glucose were determined in female Sprague-Dawley rats the subsequent three days after intraperitoneal treatment with single doses of 4.5 mg CdCl2 X 1H2O/kg, 20 mg Na2CrO4/kg, and 0.75 mg HgCl2/kg body weight. Although the pathological effects were localized within the same part of the nephron (i.e., the proximal tubule), there were marked differences with regard to the extent and time course of the parameters affected. Treatment with cadmium resulted essentially in a marked decline in sodium and glucose excretion. The administration of chromate led to a slightly to moderately elevated excretion of the enzyme activities measured with the cytosolic LDH as the most increased enzyme (ca. 500% of controls on Day 3 postadministration). Median glucose excretion was unaffected whereas sodium excretion was transiently reduced. The maximum of enzyme excretion after HgCl2 was essentially the same on the first day postadministration and the amount of enzyme activity in urine up to 20 times higher compared to that after chromium. Sodium excretion was below that of controls on Days 2 and 3, whereas glucose excretion was markedly elevated (up to 8000% of controls). The results indicate that it is possible to discriminate with the use of selected urinary enzymes, substrates, and electrolytes various kinds of nephrotoxic actions not only in different but also within the same part of the nephron.
Uremia Invest
PMID:Comparative investigations on the effects of acute intraperitoneal cadmium, chromium, and mercury exposure on the kidney. 287 41

We evaluated the effect of hemolysis, icteric discoloration, lipemia, paraproteinemia, and uremia on enzymatic methods for determining sodium, potassium, and chloride, according to the National Committee for Clinical Laboratory Standards EP7-P proposals for testing interference from endogenous substances. The sodium, potassium, and chloride assays (reagent kits supplied by Boehringer Mannheim) were based on electrolyte-dependent beta-galactosidase, pyruvate kinase, and alpha-amylase, respectively. The results were compared with those obtained by indirect ion-selective electrodes (ISE), which in turn had been validated by flame photometry. We analyzed the samples with Hitachi 717, 737, and 911 chemistry analyzers and with an IL943 flame photometer. The enzymatic results were in good agreement with those by ISE, the interference-related differences generally being without clinical significance; however, none of the enzymatic methods could analyze grossly lipemic samples.
 ...
PMID:Enzymatic determination of sodium, potassium, and chloride in abnormal (hemolyzed, icteric, lipemic, paraproteinemic, or uremic) serum samples compared with indirect determination with ion-selective electrodes. 804 91